Healthcare Oct 22, 2021 11:57 AM (GMT+8) · EqualOcean
The financial Associated Press reporter learned from Shunhao shares that its subsidiary Yunnan Lvxin mainly carries out CBD (cannabinoid) extraction, and the end products will be produced and sold in overseas legal areas through wholly-owned subsidiaries in Hong Kong and the United States. On the evening of October 21, Shunhao Co., Ltd. announced that Yunnan Lvxin, a wholly-owned subsidiary, had received the industrial marijuana processing license of Yunnan Province issued by the public security organ. At present, Yunnan Lvxin has the whole industrial chain layout of industrial marijuana planting, CBD extraction and downstream application.